Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prop 65 Andro Litigation Could Include Mini-Trial On Anabolic Steroid Status

This article was originally published in The Tan Sheet

Executive Summary

A California judge overseeing Proposition 65 litigation against androstenedione supplement marketers is expected to decide in July if a mini-trial should be held to determine whether andro is an anabolic steroid

You may also be interested in...



Prop 65 Andro Settlements Include “Corrective Advertising” Provision

Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court

Prop 65 Andro Settlements Include “Corrective Advertising” Provision

Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court

Prop 65 Andro Settlements Include “Corrective Advertising” Provision

Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court

Related Content

Topics

UsernamePublicRestriction

Register

PS094041

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel